Value of diffusion-weighted MRI in predicting early response to neoadjuvant chemotherapy of breast cancer: comparison between ROI-ADC and whole-lesion-ADC measurements.

导出原文传递

翻译打印收藏纠错

作者： Nathalie A,Hottat ^[1] ; Dominique A,Badr ^[2] ; Sophie,Lecomte ^[3] ; Tatiana,Besse-Hammer ^[4] ; Jacques C,Jani ^[5] ; Mieke M,Cannie ^[3]

作者单位： Department of Radiology, University Hospital Brugmann, Université Libre de Bruxelles, Place A. Van Gehuchten 4, 1020, Brussels, Belgium. nathalie.hottat@chu-brugmann.be. ^[1] Department of Radiology, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium. nathalie.hottat@chu-brugmann.be. ^[2] Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium. ^[3] Department of Pathology, University Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium. ^[4] Department of Clinical Research Unit University, Hospital Brugmann, Université Libre de Bruxelles, Brussels, Belgium. ^[5] Department of Radiology, University Hospital Brugmann, Université Libre de Bruxelles, Place A. Van Gehuchten 4, 1020, Brussels, Belgium. ^[6] Department of Radiology, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium. ^[7]

关键词 Breast neoplasm Diffusion magnetic resonance imaging Neoadjuvant therapy Prospective study